arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Avalo Therapeutics, Inc.

AVTX

$15.29 ▼ -1.23 (-7.45%) at close

14 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Avalo Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $205.0M

Dividend Yield —

Revenue Growth -86.6% ↘

Op. Margin None

ROIC -88.0% ↘

FCF / Share $-3.84 ↗

Trailing P/E —

Price / Book 3.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

14-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$59.00K

↓ -86.6% —

Net Income Profit after all expenses

$-78.26M

↓ -122.8% —

Operating Margin Operating profit as % of sales

-207.4%

↑ +13.2% —

FCF / Share Free cash flow per share

$-3.84

↑ +65.4% —

Long-Term Debt Long-term obligations

$14.33M

— —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue Growth YoY (%)	-86.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1183%)	-77.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1063%)	-89.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1217%)	234.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2830%)	-19.4% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-343%)	-0.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-110%)	-63.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-890%)	-34.1% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-526%)	2312.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+28803%)	—	—	—	—	—
EPS Growth YoY (%)	26.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	93.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-2463.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	N/M	N/M	60.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—
Net Income Growth YoY (%)	-122.8% Weak ↓ Weak Declining Year-over-year change in net income	-11.4% Weak ↓ Weak Declining Year-over-year change in net income	24.3% Good ↑ Good Improving Year-over-year change in net income	50.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-32.9% Weak ↑ Weak Improving Year-over-year change in net income	-295.1% Weak Weak Year-over-year change in net income	59.9% Excellent Excellent Year-over-year change in net income	N/M	N/M	-57.0% Weak ↓ Weak Declining Year-over-year change in net income	34.7% Excellent Excellent Year-over-year change in net income	-23.1% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	65.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	90.0% Excellent Excellent Year-over-year change in free cash flow	-3771.5% Weak Weak Year-over-year change in free cash flow	—	—	—	—	N/M	N/M	63.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—
Revenue CAGR 3Y (%)	-85.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-56.6% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-34.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	38.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-33.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-37.8% Weak Weak Compound annual revenue growth over 3 years	80.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-61.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-42.1% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-36.3% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-8.3% Weak Weak Compound annual revenue growth over 5 years	36.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Operating Margin (%) (%)	—	—	—	-207.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1483%)	—	—	-239.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1694%)	-214.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1530%)	49.9% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+233%)	—	—	—	—	—
Effective Tax Rate (%) (%)	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	-230.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2023%)	—	—	-238.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2084%)	-218.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1921%)	42.7% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+256%)	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	-148.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-287.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-20.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	45.1% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	0.66x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.40x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.09x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Return on Invested Capital (%)	-88.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-51.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-374.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	271.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-281.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-234.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-60.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-88.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	39.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-6136.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-66.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	64.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	57.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-62.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-45.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-130.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-112.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-102.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-166.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-44.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-56.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	32.4% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-278.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-139.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-94.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-728%)	-26.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-276%)	—	—	—	-258.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1824%)	-76.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-610%)	-191.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1377%)	42.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+184%)	—	-80.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-635%)	61.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+307%)	73.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+387%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	0.69x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+14%)	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	-0.20x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-134%)	—	—
Interest Coverage (x)	—	—	-14.21x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-12.77x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-51.82x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-15.37x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-74.88x Weak Weak Operating income divided by interest expense Optimal: > 5x	191.52x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—
Net Debt (USD)	$-15.86M	$-134.55M	$-7.42M	$-13.17M	$-54.59M	$-18.92M	$-3.61M	$3.68M	$-2.47M	$-5.13M	$-21.16M	$-6.43M	$-3.42M	$-9.52M
Debt / EBITDA (x)	—	—	—	—	—	—	—	-0.41x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.31x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue per Share (USD)	$0.00	$0.10	$6.93	$1.92	—	—	—	$6.33	$18.14	$1.57	$0.00	—	—	—
Basic EPS, GAAP (USD)	$-5.84	$-7.94	$-113.58	$-4.43	—	—	—	$-14.41	$5.04	$-22.45	$-56.54	—	—	—
Free Cash Flow per Share (USD)	$-3.84	$-11.08	$-110.47	$-2.85	—	—	—	$-1.27	$8.19	$-19.86	$-54.92	—	—	—
Book Value per Share (USD)	$4.49	$12.70	$9.11	$-1.16	$2.46	$3.93	$5.68	$6.15	$10.70	$0.26	$70.56	$-486.51	—	—
Tangible Book Value per Share (USD)	$3.92	$11.70	$-3.99	$-2.69	$0.92	$1.37	$1.13	$-7.87	$-1.57	$0.26	$70.56	$-486.51	—	—
Basic Weighted Avg Shares (shares)	13.40M	4.43M	277,727	9.41M	—	—	—	2.90M	1.53M	735,572	185,428	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Working Capital (USD)	$92.35M	$131.93M	$3.78M	$-5.70M	$41.96M	$10.78M	$5.56M	$-4.28M	$-415.07K	$1.35M	—	$7.17M	—	—
LT Debt (USD)	—	—	—	—	—	—	—	$14.33M	$0.00	$0.00	—	$5.31M	—	—
Total Equity (USD)	$83.05M	$133.03M	$7.30M	$-10.91M	$23.08M	$24.56M	$21.00M	$20.91M	$27.86M	$207.00K	$13.08M	$-26.33M	$-17.85M	$-11.38M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Sales/Revenue/Turnover (USD)	$59.00K	$441.00K	$1.92M	$18.05M	$5.40M	$6.70M	$6.75M	$18.33M	$27.81M	$1.15M	$0.00	—	—	—
Depreciation Expense (USD)	$344.00K	$169.00K	$158.00K	$166.00K	$1.66M	$1.84M	$3.88M	$4.55M	$425.48K	$26.86K	$23.51K	$28.94K	$20.03K	—
Net Income, GAAP (USD)	$-78.26M	$-35.13M	$-31.54M	$-41.66M	$-84.38M	$-63.50M	$-16.07M	$-40.05M	$11.87M	$-16.47M	$-10.49M	$-16.06M	$-13.05M	—
Operating Cash Flow (USD)	$-51.46M	$-49.06M	$-30.68M	$-26.75M	$-70.89M	$-40.54M	$-19.13M	$-3.13M	$12.58M	$-14.57M	$-10.16M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 14 years · 51 quarters

Avalo Therapeutics, Inc.

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AVTX with peers